MAY 24, 2019 3:24 PM PDT

Potential Drug Target for Anxiety

WRITTEN BY: Nouran Amin

In a study published in JAMA Psychiatry, researchers have identified new genetic contributors to anxiety and stress-related disorders—proposing a potential drug target. The study performed a genome-wide association analysis aimed at pinpointing new risk variants, genes, and pathways for the psychiatric conditions.

Among anxiety and other complex psychiatric disorders is an "ever-growing sizes of clinical and population samples are warranted to disentangle independent dimensional psychopathological factors of anxiety, trauma susceptibility, and depression associated with distinct polygenic risk signatures," authors of the study wrote.

One particular target is PDE4B, a gene that codes for an intracellular cyclic adenosine monophosphate signaling regulator and is "a promising new candidate gene … that crosses classic categorical disease boundaries."

PDE4B was previously investigated in inbred model mice for human anxiety and stress disorders and accustomed to "chronic social defeat”.

Learn more about anxiety and other mental health conditions:

"We highlight the candidate gene PDE4B as a robust risk locus (through studies in mice and humans), pointing to a potential of PDE4B inhibitors in the treatment of these disorders," says first and the corresponding author Sandra Meier, who is currently a researcher in the department of psychiatry at Dalhousie University.

In the study, researchers focused on individuals participating the Lundbeck Foundation's "Initiative for Integrative Psychiatric Research" (iPSYCH) study that compared array-based genotypes and found six dozen variants on a chromosome 1 region containing PDE4B.

"This study highlights anxiety and stress-related disorders as complex heritable phenotypes with intriguing genetic correlations not only with psychiatric traits, but also with educational outcomes and multiple obesity-related phenotypes," the authors wrote.

Source: GenomeWeb

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 13, 2020
Neuroscience
High Doses of Ketamine Can Switch Off the Brain
JUN 13, 2020
High Doses of Ketamine Can Switch Off the Brain
Researchers from the University of Cambridge, England, have found that high doses of ketamine temporarily switch off the ...
JUN 10, 2020
Drug Discovery & Development
Does Your Gut Microbiota Alter Drug Activity?
JUN 10, 2020
Does Your Gut Microbiota Alter Drug Activity?
Scientists have created a systematic way to evaluate how the microbial community in our gut influences drug behavior. Fi ...
JUN 22, 2020
Drug Discovery & Development
MDMA Has Long-Term Benefits Against PTSD
JUN 22, 2020
MDMA Has Long-Term Benefits Against PTSD
Researchers have shown that MDMA-assisted psychotherapy has therapeutic effects that last over a year in treating post-t ...
JUN 25, 2020
Drug Discovery & Development
Three New Molecular Targets for Epilepsy
JUN 25, 2020
Three New Molecular Targets for Epilepsy
A study lead by scientists at FutureNeuro discovered three new drugs hold the potential for targeting epilepsy. These dr ...
JUN 26, 2020
Drug Discovery & Development
Bacterial Virus May Treat and Prevent COVID-19 Infections
JUN 26, 2020
Bacterial Virus May Treat and Prevent COVID-19 Infections
Researchers say that a type of virus known to infect bacteria could be used to treat and prevent COVID-19 bacterial infe ...
JUL 02, 2020
Drug Discovery & Development
Electrochemicals Fuel The Path for Drug Discovery
JUL 02, 2020
Electrochemicals Fuel The Path for Drug Discovery
Drug discovery scientists at Cornell University have diverted away from the traditional synthetic chemistry into a more ...
Loading Comments...